Angelo Avogaro to United States
This is a "connection" page, showing publications Angelo Avogaro has written about United States.
Connection Strength
0.050
-
SGLT2 inhibitors and amputations in the US FDA Adverse Event Reporting System. Lancet Diabetes Endocrinol. 2017 09; 5(9):680-681.
Score: 0.025
-
SGLT2 inhibitors and diabetic ketoacidosis: data from the FDA Adverse Event Reporting System. Diabetologia. 2017 08; 60(8):1385-1389.
Score: 0.025